ATLASATLAS fair value
MX$43.88
Below fair value · 64% discount
Range: MX$34–MX$57Fair valuePrice
Genomma Lab Internacional S.A.B. de C.V (LABB.MX)
Genomma Lab Internacional S.A.B. de C.V stock price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · Bolsa Mexicana de Valores · Mexico
MX$15.66▲ +2.15%
Prices as of Oct 26, 2026 · MXN
Chance of rising in 1 month
51%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Genomma Lab Internacional S.A.B. de C.V in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Genomma Lab Internacional S.A.B. de C.V
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates Genomma Lab Internacional S.A.B. de C.V's fair value at about MX$43.88 per share (reasonable range: MX$33.69 to MX$57.16). At MX$15.66, the stock trades 64% below it.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is low. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Genomma Lab Internacional S.A.B. de C.V a 51% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between MX$14.96 and MX$16.47; in 9 out of 10, between MX$13.74 and MX$17.94. Estimated annual volatility is 25%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- MX$13.6B
- Market cap (USD)
- $734M
- P/E ratio
- 9.1
- Dividend yield
- 5.45%
- 52-week high
- MX$19.48
- 52-week low
- MX$12.22
- Revenue (12 months)
- MX$17.1B
- Gross margin
- 62.6%
- Operating margin
- 19.2%
- Net margin
- 10.0%
- Beta
- 0.13
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Genomma Lab Internacional S.A.B. de C.V sits below fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks LABB.MX has traded between MX$12.22 and MX$19.48. Today it is 19.6% below that high and 28% above its low.
On the business: net margin is 10.0%; it trades at 9.1 times earnings.
Its beta is 0.13: it tends to move less than the market.
About the company
Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally.
Want to see everything about Genomma Lab Internacional S.A.B. de C.V?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is Genomma Lab Internacional S.A.B. de C.V (LABB.MX) fair value?
About MX$43.88 per share according to ATLAS (reasonable range: MX$33.69 to MX$57.16). With the stock at MX$15.66, it is 64% below it.
What is the chance LABB.MX goes up next month?
51%: close to a coin flip. In half of the simulated outcomes, LABB.MX ends the month between MX$14.96 and MX$16.47.
How big is Genomma Lab Internacional S.A.B. de C.V and what is its P/E ratio?
Genomma Lab Internacional S.A.B. de C.V's market capitalization is MX$13.6B. Its price-to-earnings (P/E) ratio is 9.1: you pay MX$9.13 for each MX$1.00 of yearly earnings.
Does Genomma Lab Internacional S.A.B. de C.V pay a dividend?
Yes. LABB.MX's current dividend yield is 5.45% at today's price (MX$15.66).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer